KARMA 17 12 2015


via Twitter

The pharmaceutical CEO reviled for raising the price of life-saving drugs for personal gain has been arrested for securities fraud. Martin Shkreli, 32, is accused of taking stocks from Retrophin Inc. to pay off unrelated debts. He started the biotech firm in 2011. Prosecutors say he made secret payoffs and set up fake deals.